HARRINGTONINE,EPI: (156930)

Compound Details

NameHARRINGTONINE,EPI:
Compound class58161E812146170
Compound codeISOQUINOLINE ALKALOID

Summary

Compound class: 58161E812146170

Experiments: 11

View Experiments

Experiments (11)

Filters
Worktypes (13)
9
7
2
2
1
1
1
1
1
1
1
1
1
No match
Pharmacology (4)
7
1
1
2
No match
Compounds (2)
11
2
No match
Organisms (4)
7
2
1
1
No match
11 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
1057217
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1057214
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1053156
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FOR
Empty organism
1057216
PHARMACOLOGY OF COMPOUND - IN VIVORADIOIMMUNOASSAY USEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1057212
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
994591
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDORD SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Cephalotaxus hainanensis (CEPHALOTAXACEAE)
818661
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PROTEIN SYNTHESIS INHIBITION
Empty organism
818660
PHARMACOLOGY OF COMPOUND - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
DNA SYNTHESIS INHIBITION
Empty organism
1057218
SYNERGISM REPORTED FORPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1057213
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1057215
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
Show SPARQL Queries (1)